Article
Nature 448, 318-324 (19 July 2007) | doi:10.1038/nature05944; Received 27 February 2007; Accepted 22 May 2007; Published online 6 June 2007
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Marius Wernig1,6, Alexander Meissner1,6, Ruth Foreman1,2,6, Tobias Brambrink1,6, Manching Ku3,6, Konrad Hochedlinger1,7, Bradley E. Bernstein3,4,5 & Rudolf Jaenisch1,2
- Whitehead Institute for Biomedical Research and,
- Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA
- Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
- Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA
- Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA
- These authors contributed equally to this work.
- Present address: Center for Regenerative Medicine and Cancer Center, Massachusetts General Hospital, Harvard Medical School and Harvard Stem Cell Institute, Boston, Massachusetts 02414, USA.
Correspondence to: Rudolf Jaenisch1,2 Correspondence and requests for materials should be addressed to R.J. (Email: jaenisch@wi.mit.edu).
Abstract
Nuclear transplantation can reprogramme a somatic genome back into an embryonic epigenetic state, and the reprogrammed nucleus can create a cloned animal or produce pluripotent embryonic stem cells. One potential use of the nuclear cloning approach is the derivation of 'customized' embryonic stem (ES) cells for patient-specific cell treatment, but technical and ethical considerations impede the therapeutic application of this technology. Reprogramming of fibroblasts to a pluripotent state can be induced in vitro through ectopic expression of the four transcription factors Oct4 (also called Oct3/4 or Pou5f1), Sox2, c-Myc and Klf4. Here we show that DNA methylation, gene expression and chromatin state of such induced reprogrammed stem cells are similar to those of ES cells. Notably, the cells—derived from mouse fibroblasts—can form viable chimaeras, can contribute to the germ line and can generate live late-term embryos when injected into tetraploid blastocysts. Our results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Turning skin into embryonic stem cellsNature Medicine News and Views (01 Jul 2007)
Debugging cellular reprogrammingNature Cell Biology News and Views (01 Aug 2007)
See all 9 matches for News And ViewsRESEARCH
Emx2 patterns the neocortex by regulating FGF positional signalingNature Neuroscience Article (01 Aug 2003)
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell typesNature Biotechnology Research (01 Aug 2008)
See all 36 matches for Research
